Skip to main content
logo
Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
10.97
+0.05 (0.46%)
At close: Aug 14, 2026, 4:00 PM EDT
10.77
-0.20 (-1.80%)
After-hours: Aug 14, 2026, 7:34 PM EDT

Immix Biopharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-39.92-29.44-21.61-15.43-8.23-24.38
Depreciation & Amortization
0.490.360.120.0100
Other Amortization
-----0.06
Stock-Based Compensation
2.592.443.022.570.620.22
Other Operating Activities
---0.08-0.17-22.91
Change in Accounts Payable
-0.551.034.42.431.13-0.11
Change in Income Taxes
0.032.06-0.97-0.89-0.240.1
Change in Other Net Operating Assets
-1.13-0.380.540.11-0.7-0.38
Operating Cash Flow
-38.5-23.93-14.6-11.37-7.41-1.59
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.59-0.73-1.18-0.05--0
Investment in Securities
-8.56-6.48----
Investing Cash Flow
-9.15-7.21-1.18-0.05--0

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-----0.2
Total Debt Issued
-----0.2
Short-Term Debt Repaid
-----0.05-
Total Debt Repaid
-----0.05-
Net Debt Issued (Repaid)
-----0.050.2
Issuance of Common Stock
261.66107.5215.9515.522.9118.65
Repurchase of Common Stock
-----0.1-
Other Financing Activities
-0.14-0.14--0.060.47-
Financing Cash Flow
261.52107.3915.9515.463.2318.85

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.020-00.03-0.03-0.01
Net Cash Flow
213.8576.250.174.07-4.2117.25

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-39.09-24.66-15.77-11.42-7.41-1.59
Free Cash Flow Growth
------
Free Cash Flow Per Share
-0.82-0.75-0.56-0.66-0.53-0.43
Levered Free Cash Flow
-25.39-13.61-7.55-5.94-4.31-2.1
Unlevered Free Cash Flow
-25.39-13.61-7.55-5.94-4.31-2.04

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
----0.010
Change in Working Capital
-1.652.73.971.650.2-0.39
SEC Filings: 10-K · 10-Q